失眠治疗对认知功能的影响:随机对照试验的元分析
Fang Wu1, Xiao Li1, Ya-Nan Guo1
1Department of Sleep Medicine, Second Affiliated Hospital of Xinxiang Medical University; Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders; Brain Institute, Henan Academy of Innovations in Medical Science, Xinxiang, PR China.
非药物失眠治疗显著改善认知功能,特别是记忆力和注意力. 较长的治疗持续时间与更大的认知益处相关,突出了它们对整体福祉的重要性.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 睡眠医学 睡眠医学
背景情况:
- 失眠在全球范围内影响认知功能,需要有效的治疗探索.
- 现有的药理和非药理干预措施表现出多种效果,需要优化策略.
研究的目的:
- 系统评估失眠治疗对认知功能的影响.
- 确定哪些类型的干预措施产生了最显著的认知改善.
主要方法:
- 在主要数据库 (PubMed,EMBASE,Web of Science,Cochrane,PsychInfo) 进行了全面的文献搜索,直到2024年8月.
- 包括24项随机对照研究;元分析计算了标准化平均差异 (SMD) 和95%置信区间 (CI).
- 进行了敏感性分析,评估了出版偏差,并进行了元回归.
主要成果:
- 非药物干预显著增强了认知功能 (SMD:0.27).
- 记忆 (SMD:1.18),注意力 (SMD:0.32) 和日常生活活动 (SMD:0.29) 的改善.
- 较长的随访时间与更大的认知益处有关 (SMD:0.34).
结论:
- 非药物治疗失眠对于改善认知功能至关重要.
- 量身定制的治疗方法对于优化认知结果和福祉至关重要.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
相关概念视频
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Blind Procedures
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
